Pharmacokinetics of combined treatment with praziquantel and albendazole in neurocysticercosis.
about
A research agenda for helminth diseases of humans: intervention for control and eliminationRepurposing drugs for the treatment and control of helminth infectionsLack of Clinical Pharmacokinetic Studies to Optimize the Treatment of Neglected Tropical Diseases: A Systematic ReviewMedical management of neurocysticercosis.Efficacy of combined antiparasitic therapy with praziquantel and albendazole for neurocysticercosis: a double-blind, randomised controlled trial.Solitary cysticercus granuloma.Use of anti-epileptic drugs in a tertiary care hospital of Eastern India with emphasis on epilepsy due to neurocysticercosis.Albendazole and Corticosteroids for the Treatment of Solitary Cysticercus Granuloma: A Network Meta-analysis.Diagnosis and treatment of neurocysticercosis.Cysticidal Efficacy of Combined Treatment With Praziquantel and Albendazole for Parenchymal Brain Cysticercosis.CYP2J2 and CYP2C19 are the major enzymes responsible for metabolism of albendazole and fenbendazole in human liver microsomes and recombinant P450 assay systems.Cysticercosis of the central nervous system: how should it be managed?Pharmacokinetic variability of anthelmintics: implications for the treatment of neurocysticercosis.Parasitoses of the human central nervous system.Current status and future perspectives on the medical treatment of neurocysticercosis.Clinical management of neurocysticercosis.A review of pharmacokinetic drug-drug interactions with the anthelmintic medications albendazole and mebendazole.Neurocysticercosis: a review on status in India, management, and current therapeutic interventions.Effect of nitazoxanide on albendazole pharmacokinetics in cerebrospinal fluid and plasma in rats.Update on the Diagnosis and Management of Neurocysticercosis.Inoperable cerebral alveolar echinococcosis controlled with high dosages of albendazole adjusted with monitoring of blood levels.Neglected infections of poverty in Texas and the rest of the United States: management and treatment options.Novel rat model for neurocysticercosis using Taenia solium.
P2860
Q21562256-5B88C1E4-D4B7-4B03-9357-41A46009F098Q26823355-B4A0A8A0-6775-49D7-B8EE-9AE1307B1C26Q33658786-04FFCFA5-62B0-4198-8480-9B1F6EC88688Q34074147-9E67254F-9695-4458-B850-C21A0C3318A6Q34150372-10C335B5-24BE-424D-8A70-97CE6D6BDCD6Q34306018-4305A757-D789-4C8A-A558-44D9FA21F692Q35732499-D27FB637-915F-45C6-8DB5-DDA29A68BF1FQ35915625-86B105F6-7CE1-448B-9005-F49A0DB094CCQ35953198-4CEA3A9E-C707-4CEE-B9A6-C924B256A99FQ36915099-ECD4DE25-1AE4-4033-9769-837CF74A8FB3Q37263390-0A81761E-281F-489C-9D10-BB2F5D177187Q37905499-1607B663-93DD-4AC4-A8C6-4E8D24594F49Q37964749-9679AC2B-70A4-4A23-91D5-18E6640EB82CQ38050556-B7D1D5E0-73DD-4125-A833-55AB65293B2DQ38069637-7C0834B7-111F-46C6-ABF4-7FB881C74B16Q38189498-D62A8892-D43F-4DCF-A7CF-F2F35769B41BQ38359488-6F0F5FBD-6E94-4EE4-AB62-BAD9040BF70CQ38806842-34F2213A-8EB9-4D52-8FF7-10CA6CBBA709Q38875211-79B52948-4E5A-4BA4-BA67-FBDD858EA2E2Q38992622-F800EF71-DA5F-4593-A8BB-3F04D31433B1Q39487707-7009D997-DC8A-4A1F-AF06-DB26B4EFC5CFQ40281592-87340CD8-ADF3-440C-B4D5-DBFC8053487CQ41087456-D369D308-8E4B-4FEA-9295-879A030C28F9
P2860
Pharmacokinetics of combined treatment with praziquantel and albendazole in neurocysticercosis.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Pharmacokinetics of combined t ...... ndazole in neurocysticercosis.
@ast
Pharmacokinetics of combined t ...... ndazole in neurocysticercosis.
@en
type
label
Pharmacokinetics of combined t ...... ndazole in neurocysticercosis.
@ast
Pharmacokinetics of combined t ...... ndazole in neurocysticercosis.
@en
prefLabel
Pharmacokinetics of combined t ...... ndazole in neurocysticercosis.
@ast
Pharmacokinetics of combined t ...... ndazole in neurocysticercosis.
@en
P2093
P2860
P50
P1476
Pharmacokinetics of combined t ...... ndazole in neurocysticercosis.
@en
P2093
E Javier Pretell
Herbert Saavedra
Isidro Gonzales
Javier A Bustos
John Horton
Osvaldo M Takayanagui
Pierina S Bonato
P2860
P356
10.1111/J.1365-2125.2011.03945.X
P407
P50
P577
2011-07-01T00:00:00Z